SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant.

Eric A Meyerowitz, Aaron Richterman
Author Information
  1. Eric A Meyerowitz: Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. Electronic address: emeyerowit@montefiore.org.
  2. Aaron Richterman: Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant transmits much more rapidly than prior SARS-CoV-2 viruses. The primary mode of transmission is via short range aerosols that are emitted from the respiratory tract of an index case. There is marked heterogeneity in the spread of this virus, with 10% to 20% of index cases contributing to 80% of secondary cases, while most index cases have no subsequent transmissions. Vaccination, ventilation, masking, eye protection, and rapid case identification with contact tracing and isolation can all decrease the transmission of this virus.

Keywords

References

  1. Ann Intern Med. 2021 Jun;174(6):794-802 [PMID: 33556277]
  2. Science. 2021 Feb 5;371(6529): [PMID: 33303686]
  3. PLoS One. 2020 Nov 11;15(11):e0242128 [PMID: 33175914]
  4. J Prev Med Public Health. 2021 May;54(3):161-165 [PMID: 34092061]
  5. MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1214-1219 [PMID: 34473683]
  6. EClinicalMedicine. 2021 Oct;40:101129 [PMID: 34541481]
  7. J Korean Med Sci. 2020 Nov 23;35(45):e396 [PMID: 33230987]
  8. Nature. 2021 Apr;592(7852):116-121 [PMID: 33106671]
  9. Science. 2003 Jun 20;300(5627):1966-70 [PMID: 12766207]
  10. PLoS One. 2021 Jul 29;16(7):e0255212 [PMID: 34324570]
  11. Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14595-14600 [PMID: 27872300]
  12. Emerg Infect Dis. 2020 Jun;26(6):1059-1066 [PMID: 32187007]
  13. Infect Dis Poverty. 2015 Feb 24;4:13 [PMID: 25737782]
  14. Science. 2022 Jan 14;375(6577):eabi9069 [PMID: 34855513]
  15. PLoS Comput Biol. 2021 Jun 17;17(6):e1009122 [PMID: 34138866]
  16. Public Health. 2020 Dec;189:54-59 [PMID: 33160088]
  17. N Engl J Med. 2020 Mar 26;382(13):1199-1207 [PMID: 31995857]
  18. Emerg Infect Dis. 2019 Jan;25(1):1-4 [PMID: 30560777]
  19. Lancet Infect Dis. 2021 May;21(5):617-628 [PMID: 33476567]
  20. Clin Infect Dis. 2021 Oct 5;73(7):e1878-e1880 [PMID: 32856692]
  21. Science. 1982 Feb 26;215(4536):1053-60 [PMID: 7063839]
  22. Open Forum Infect Dis. 2021 May 19;9(2):ofab259 [PMID: 35071679]
  23. Lancet Infect Dis. 2014 Jan;14(1):50-56 [PMID: 24239323]
  24. Clin Infect Dis. 2022 Aug 24;75(1):e97-e101 [PMID: 34718446]
  25. Indoor Air. 2007 Jun;17(3):211-25 [PMID: 17542834]
  26. Lancet Infect Dis. 2022 Feb;22(2):183-195 [PMID: 34756186]
  27. Clin Infect Dis. 2022 May 30;74(10):1722-1728 [PMID: 34358292]
  28. Wellcome Open Res. 2020 Apr 9;5:67 [PMID: 32685698]
  29. Clin Epidemiol Glob Health. 2021 Jan-Mar;9:157-161 [PMID: 32869006]
  30. Virus Evol. 2021 Sep 02;7(2):veab073 [PMID: 34642604]
  31. BMJ. 2022 Jan 13;376:o89 [PMID: 35027360]
  32. BMJ Glob Health. 2020 May;5(5): [PMID: 32467353]
  33. PLoS Med. 2020 Sep 22;17(9):e1003346 [PMID: 32960881]
  34. Lancet. 2021 Dec 4;398(10316):2093-2100 [PMID: 34756184]
  35. Clin Infect Dis. 2022 Mar 23;74(6):1097-1100 [PMID: 34145449]
  36. Lancet Infect Dis. 2020 Aug;20(8):911-919 [PMID: 32353347]
  37. Eval Health Prof. 2021 Dec;44(4):327-332 [PMID: 34592838]
  38. Nat Commun. 2020 Nov 2;11(1):5518 [PMID: 33139704]
  39. Euro Surveill. 2021 Dec;26(50): [PMID: 34915975]
  40. Sci Rep. 2021 Aug 5;11(1):15960 [PMID: 34354189]
  41. Nature. 2022 Mar;603(7902):679-686 [PMID: 35042229]
  42. J Med Virol. 2022 Mar;94(3):821-822 [PMID: 34596249]
  43. N Engl J Med. 2021 Apr 15;384(15):1412-1423 [PMID: 33626250]
  44. Science. 2021 Sep 03;373(6559):1142-1146 [PMID: 34315827]
  45. Am J Respir Crit Care Med. 2001 Jan;163(1):7-8 [PMID: 11208616]
  46. Nat Commun. 2022 Jan 24;13(1):460 [PMID: 35075154]
  47. JAMA Intern Med. 2021 Jul 1;181(7):960-966 [PMID: 33885715]
  48. Nature. 2022 Feb;602(7898):682-688 [PMID: 35016197]
  49. Lancet. 2013 Aug 24;382(9893):694-9 [PMID: 23831141]
  50. Lancet Reg Health Eur. 2022 Jan;12:100252 [PMID: 34729548]
  51. Nat Med. 2020 Nov;26(11):1714-1719 [PMID: 32943787]
  52. Lancet Infect Dis. 2021 May;21(5):629-636 [PMID: 33545090]
  53. PLoS Pathog. 2022 Sep 30;18(9):e1010876 [PMID: 36178969]
  54. Nat Med. 2021 Dec;27(12):2127-2135 [PMID: 34650248]
  55. Science. 2021 Dec 10;374(6573):1353-1360 [PMID: 34698504]
  56. Clin Infect Dis. 2022 May 3;74(9):1678-1681 [PMID: 34453527]
  57. Emerg Infect Dis. 2022 Feb;28(2):460-462 [PMID: 34860154]
  58. Cell. 2021 Sep 30;184(20):5077-5081 [PMID: 34534444]
  59. Ann Intern Med. 2021 Dec;174(12):1710-1718 [PMID: 34748374]
  60. Nature. 2005 Nov 17;438(7066):355-9 [PMID: 16292310]
  61. Clin Microbiol Infect. 2022 Apr;28(4):612.e1-612.e7 [PMID: 34826623]
  62. JAMA Netw Open. 2021 Jun 1;4(6):e2114514 [PMID: 34160607]
  63. JAMA. 2019 Sep 3;322(9):824-833 [PMID: 31479137]
  64. Emerg Infect Dis. 2020 Sep;26(9): [PMID: 32433907]
  65. Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S154-S162 [PMID: 33150375]
  66. Nat Med. 2021 Dec;27(12):2108-2110 [PMID: 34728830]
  67. Clin Infect Dis. 2021 Jun 15;72(12):2225-2240 [PMID: 33104186]
  68. Science. 2021 Apr 9;372(6538): [PMID: 33658326]
  69. J Infect. 2021 Oct;83(4):e1-e3 [PMID: 34419559]
  70. Nature. 2021 Apr;592(7852):122-127 [PMID: 33636719]
  71. Int J Infect Dis. 2021 Jun;107:247-250 [PMID: 33901654]
  72. Emerg Infect Dis. 2020 Aug;26(8):1666-1670 [PMID: 32324530]
  73. Clin Infect Dis. 2022 Aug 24;75(1):e715-e725 [PMID: 34922338]
  74. J Infect Dis. 2021 Feb 13;223(3):362-369 [PMID: 33119738]
  75. Influenza Other Respir Viruses. 2022 Jan;16(1):63-71 [PMID: 34605181]
  76. J Infect Dis. 2021 Oct 28;224(8):1316-1324 [PMID: 34302469]
  77. Nat Med. 2022 Jul;28(7):1491-1500 [PMID: 35395151]
  78. Ann Epidemiol. 2020 Dec;52:46-53.e2 [PMID: 32711053]
  79. MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):779-784 [PMID: 34043610]
  80. Ann Intern Med. 2021 Mar;174(3):335-343 [PMID: 33205991]
  81. N Engl J Med. 2022 Feb 10;386(6):599-601 [PMID: 35030645]
  82. Lancet Microbe. 2021 Jan;2(1):e13-e22 [PMID: 33521734]
  83. PLoS Pathog. 2021 Sep 7;17(9):e1009883 [PMID: 34492088]
  84. Lancet Reg Health West Pac. 2022 Jan;18:100360 [PMID: 34961854]
  85. Emerg Infect Dis. 2022 Feb;28(2):407-410 [PMID: 34906289]
  86. NPJ Vaccines. 2021 May 13;6(1):74 [PMID: 33986272]
  87. Infect Dis Model. 2021;6:988-996 [PMID: 34395957]
  88. Clin Infect Dis. 2021 Oct 5;73(7):1805-1813 [PMID: 33185244]
  89. Emerg Infect Dis. 2022 Mar;28(3):501-509 [PMID: 34965365]
  90. Clin Infect Dis. 2018 Apr 3;66(8):1270-1275 [PMID: 29228134]
  91. Infect Control Hosp Epidemiol. 2022 Mar;43(3):344-350 [PMID: 33775264]
  92. Science. 2021 Jul 9;373(6551):162-163 [PMID: 34244400]
  93. Epidemiol Infect. 2021 Apr 30;149:e110 [PMID: 33928885]
  94. China CDC Wkly. 2021 Jul 2;3(27):584-586 [PMID: 34594941]
  95. Am Rev Respir Dis. 1962 Apr;85:511-25 [PMID: 14492300]
  96. Clin Infect Dis. 2021 Nov 2;73(9):1693-1695 [PMID: 33704451]
  97. Science. 2021 Jul 9;373(6551): [PMID: 34035154]
  98. J Infect Dis. 2008 Jan 15;197(2):270-8 [PMID: 18194088]
  99. MMWR Morb Mortal Wkly Rep. 2021 Oct 08;70(40):1425-1426 [PMID: 34618799]
  100. PLoS Biol. 2020 Nov 12;18(11):e3000897 [PMID: 33180773]
  101. JAMA Intern Med. 2020 Sep 1;180(9):1156-1163 [PMID: 32356867]
  102. N Engl J Med. 2021 Aug 5;385(6):562-566 [PMID: 34347959]
  103. Epidemiol Infect. 2011 Sep;139(9):1418-24 [PMID: 21087539]
  104. JAMA Netw Open. 2021 May 3;4(5):e2110789 [PMID: 34019089]
  105. J Med Virol. 2022 May;94(5):2265-2268 [PMID: 34967453]
  106. Int J Environ Res Public Health. 2021 Jul 22;18(15): [PMID: 34360046]
  107. Science. 2021 Aug 27;373(6558): [PMID: 34446582]
  108. Eur J Epidemiol. 2021 Feb;36(2):179-196 [PMID: 33634345]
  109. Lancet Digit Health. 2020 Dec;2(12):e658-e666 [PMID: 33078140]
  110. Lancet. 2021 Jan 9;397(10269):93-94 [PMID: 33347812]
  111. JAMA. 2020 Dec 1;324(21):2155-2156 [PMID: 33185657]
  112. MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025 [PMID: 32759921]
  113. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610 [PMID: 32407303]
  114. N Engl J Med. 2021 Oct 7;385(15):1393-1400 [PMID: 34525275]
  115. Am J Infect Control. 2021 Jul;49(7):900-906 [PMID: 33347937]
  116. Clin Infect Dis. 2021 Feb 16;72(4):604-610 [PMID: 32726405]
  117. J Korean Med Sci. 2020 Nov 30;35(46):e415 [PMID: 33258335]
  118. Euro Surveill. 2022 Mar;27(10): [PMID: 35272744]
  119. Clin Infect Dis. 2021 Nov 16;73(10):1747-1749 [PMID: 34415335]
  120. Emerg Infect Dis. 2020 Jul;26(7):1628-1631 [PMID: 32240078]
  121. MMWR Morb Mortal Wkly Rep. 2021 Aug 06;70(31):1059-1062 [PMID: 34351882]
  122. JAMA. 2020 Aug 4;324(5):441-442 [PMID: 32749495]
  123. JAMA Netw Open. 2021 Oct 1;4(10):e2135566 [PMID: 34714347]
  124. Emerg Infect Dis. 2020 Sep;26(9): [PMID: 32521222]
  125. Build Environ. 2021 Jul;198:107839 [PMID: 33875902]
  126. Indoor Air. 2022 Jan;32(1):e12946 [PMID: 34704625]
  127. Am J Epidemiol. 2011 Sep 1;174(5):505-14 [PMID: 21749971]
  128. N Engl J Med. 2022 Feb 24;386(8):744-756 [PMID: 34986294]
  129. PLoS Med. 2007 Feb;4(2):e68 [PMID: 17326709]
  130. Lancet Infect Dis. 2017 Dec;17(12):e420-e428 [PMID: 28757186]
  131. J Hosp Infect. 2022 Jan;119:126-131 [PMID: 34752804]
  132. Lancet. 2020 Jun 27;395(10242):1973-1987 [PMID: 32497510]
  133. BMJ. 2021 Sep 23;374:n2320 [PMID: 34556464]
  134. Clin Infect Dis. 2021 Oct 5;73(7):1318 [PMID: 33433558]
  135. BMC Med. 2009 Sep 10;7:45 [PMID: 19744314]
  136. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1167-1169 [PMID: 34437521]
  137. Ann Intern Med. 2020 May 05;172(9):577-582 [PMID: 32150748]
  138. BMC Infect Dis. 2013 Jul 01;13:300 [PMID: 23815441]
  139. N Engl J Med. 2021 Dec 23;385(26):2485-2487 [PMID: 34731553]
  140. Clin Microbiol Infect. 2021 Apr;27(4):511-519 [PMID: 33484843]
  141. N Engl J Med. 2020 Apr 16;382(16):1564-1567 [PMID: 32182409]
  142. Infect Control Hosp Epidemiol. 2022 Oct;43(10):1408-1412 [PMID: 34593066]
  143. JAMA Netw Open. 2020 Sep 1;3(9):e2020498 [PMID: 32902653]
  144. Lancet Infect Dis. 2021 Sep;21(9):1203-1204 [PMID: 34352224]
  145. Environ Sci Technol Lett. 2021 Feb 9;8(2):168-175 [PMID: 34192125]
  146. Nat Med. 2020 Aug;26(8):1205-1211 [PMID: 32546824]
  147. Science. 2021 Dec 24;374(6575):1626-1632 [PMID: 34735219]
  148. Clin Infect Dis. 2022 Sep 14;75(5):893-896 [PMID: 35134167]
  149. Lancet Reg Health West Pac. 2021 Dec;17:100299 [PMID: 34746899]
  150. Lancet. 2021 Sep 4;398(10303):837-838 [PMID: 34388398]
  151. Nature. 2021 Nov;599(7883):114-119 [PMID: 34488225]
  152. N Engl J Med. 2020 Dec 3;383(23):2291-2293 [PMID: 33176080]
  153. Science. 2020 Dec 18;370(6523):1464-1468 [PMID: 33184236]
  154. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):714-721 [PMID: 32525850]
  155. Euro Surveill. 2021 Aug;26(31): [PMID: 34355689]
  156. Health Aff (Millwood). 2020 Aug;39(8):1419-1425 [PMID: 32543923]
  157. Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9 [PMID: 22323300]
  158. Science. 2021 Nov 19;374(6570):995-999 [PMID: 34648303]
  159. Nat Commun. 2021 Mar 12;12(1):1653 [PMID: 33712573]
  160. Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S170-S176 [PMID: 32964919]
  161. PLoS Curr. 2014 Sep 08;6: [PMID: 25642358]
  162. MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99 [PMID: 33476315]
  163. Ann Intern Med. 2021 Jan;174(1):69-79 [PMID: 32941052]

MeSH Term

COVID-19
Humans
SARS-CoV-2
Vaccination

Word Cloud

Created with Highcharts 10.0.0SARS-CoV-2indexcasesrespiratorytransmissioncasevirusVaccinationTransmissionDeltasevereacutesyndromecoronavirus2deltavarianttransmitsmuchrapidlypriorvirusesprimarymodeviashortrangeaerosolsemittedtractmarkedheterogeneityspread10%20%contributing80%secondarysubsequenttransmissionsventilationmaskingeyeprotectionrapididentificationcontacttracingisolationcandecreasePreventionEraVariantAerosolCOVID-19OverdispersionSuperspreading

Similar Articles

Cited By